Advances in Hematological Malignancies
Recent centuries have witnessed remarkable advancements in the domain of hematological malignancies. Novel therapies such as targeted drugs, immunotherapies, and manipulation are altering the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative approaches, offering potential for more successful